GLPwatch
Trials (2036)
Page 15 of 34.
- Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
- Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
- Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Semaglutide in Treatment of Obesity
- Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
- Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
- Tailored Exercise Training Study Among Adults With HFpEF
- Prevention of Progression of Prediabetes, Obesity and CV Risk
- A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
- Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- A Study of LY3305677 in Healthy Participants
- Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
- Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- Triple Therapy in T1DM
- Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
- Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
- Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
- Real-world Health Outcomes in Canadian Patients Using Semaglutide
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
- Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
- A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body
- The Microvascular Function of GLP-1 and Its Analogues
- Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
- GLP1R in Parkinson's Disease
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
- 3mg Liraglutide for Overweight or Obesity
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
- Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
- Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
- A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
- The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
- Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Data
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
- A Study of LY3537021 in Healthy Participants
- Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects
- Comprehensive Clinical Evaluation Study of GLP-1RA
- A Study of CS060380 Tablets in Patients With MASH and Obesity
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes
- A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity